Integrating CRISPR/Cas technology with clinical trials: Principles, progress and challenges

CRISPR represent a groundbreaking genome-editing technology that has revolutionized genetic modification. This innovative tool offers an unparalleled revolution in the future treatment of genetic disorders, neurological diseases, infectious diseases and cancer. Despite the rapid expansion of CRISPR...

Descripció completa

Dades bibliogràfiques

Autors principals:	Piao Yang, Mohadeseh Khoshandam, Iman Bhia, Sevil Raji, Hossein Soltaninejad, Saman Hosseinkhani, Mehdi Sani, Amir Ali Hamidieh, Mohsen Sheykhhasan
Format:	Artigo
Idioma:	Inglês
Publicat:	KeAi Communications Co., Ltd. 2025-12-01
Col·lecció:	Asian Journal of Pharmaceutical Sciences
Matèries:	CRISPR/Cas systems Gene editing Genetic therapy Genetic diseases Clinical trials
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1818087625000522
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!